-

Vetter Aligns its Development Service Laboratory Portfolio Under One Roof

  • Bundling of competencies optimizes workflow of customer projects
  • Further expansion of laboratory space to continue through 2020
  • Company continues to invest strongly in its future

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year. Designed to improve workflow and enhance customer benefits within the daily support in complex development projects, the services at the 1,800 sqm building include process development as well as functional and specification testing of packaging systems, chemical-analytical and biochemical analysis and particle characterization. State-of-the-art non-GMP laboratory space and equipment combined with a leading-edge GMP analytical laboratory now allow for increased capacity and optimized work spaces.

At present, more than fifty employees work in the new labs. By bringing the laboratories under one roof, employees easily share expertise and know-how to improve and simplify information exchange, leverage synergies and reinforce an overall positive work atmosphere. Overall customer will benefit from the alignment. Prior to the bundling of its laboratories, the development studies and the corresponding analytical services for testing during process or packaging material development took place in several labs at different locations in Ravensburg and Langenargen. By sequencing these services, processes have been synchronized and handling issues reduced, all leading to numerous benefits primarily for customer projects, but also for projects undertaken within the company.

“Our customers are excited and impressed with the new and modern development laboratories and their increased capacity. Now they can follow a complete development process and its individual steps, since it proceeds throughout the labs, all within the same building,” said Dr. Claus Feussner, Senior Vice President Development Service. Expansion will continue within the building throughout the year and includes still more lab space and the provision of additional innovative analytical equipment and lyophilizer capacity.

Vetter is also committed to further process optimization and capacity expansion in filling and secondary packaging of injectables at all its sites. This is based on increased global customer demand for the development and commercialization of promising new compounds.

Contacts

Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Media Relations
Eywiesenstrasse 5
88212 Ravensburg
Germany
Phone: +49 (0)751-3700-3729
E-mail: PRnews@vetter-pharma.com

Vetter


Release Summary
CDMO Vetter has brought together its development laboratories in one site. State-of-the-art laboratories increase capacity and optimize work spaces.
Release Versions

Contacts

Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Media Relations
Eywiesenstrasse 5
88212 Ravensburg
Germany
Phone: +49 (0)751-3700-3729
E-mail: PRnews@vetter-pharma.com

More News From Vetter

Vetter Starts Construction of a New Production Site in Germany

SAARLOUIS, Germany & RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading Contract Development and Manufacturing Organization (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony today. During the first construction phase, the company will build a state-of-the-art facility for the commercial production of injectable drugs on the 95-acre industrial site. In total, Vetter will invest almost half a billion euros in the site by...

Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering, the company is taking important steps to provide necessary capacity, advanced technologies, and specialized expertise in response to rising demand for in-human trial material. By further strengthening i...

Vetter Recognized as 2026 CDMO Leadership Awards Winner

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), receives recognition as CDMO of the year in the category “Finished Dose” of the 2026 CDMO Leadership Awards. The award honors the company for exhibiting valued characteristics as a reliable and experienced partner, reaffirming its commitment to offering quality and technical know-how to its customers. The acknowledgment reinforces Vetter’s strategic role as a trusted part...
Back to Newsroom